Hong Fang Song - 03 Sep 2025 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Reporting relationship: Director
Issuer ticker: CGON
Reported as of: 03 Sep 2025
Net transaction value: -$2,779,542
SEC form: 4
Accepted by SEC: 04 Sep 2025, 17:00:07 UTC
Prior SEC filing: 06 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Hong Fang Song

Key filing fact

Hong Fang Song filed Form 4 for CG Oncology, Inc. (CGON) on 04 Sep 2025.

Key facts

This page summarizes Hong Fang Song's Form 4 filing for CG Oncology, Inc. (CGON).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Sep 2025, 17:00.

Change

Previous filing in this sequence was filed on 06 Jun 2025.
Current net transaction value: -$2,779,542.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002008157 Primary reporting owner

Song Hong Fang

Relationship: Director
Address: C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE
Signature: /s/ Joshua F. Patterson, Attorney-in-Fact for Hong Fang Song
Signature date: 04 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGON transaction

Common Stock

Sale

Transaction value: $1,923,582
Shares: -69,695
Change %: -2.3%
Price: $27.60
Shares after: 2,934,236
Date: 03 Sep 2025
Ownership: By Chaming Jade Limited
Footnotes: F1, F2, F3

CGON transaction

Common Stock

Sale

Transaction value: $850,165
Shares: -30,105
Change %: -1%
Price: $28.24
Shares after: 2,904,131
Date: 03 Sep 2025
Ownership: By Charming Jade Limited
Footnotes: F2, F3, F4

CGON transaction

Common Stock

Sale

Transaction value: $2,896
Shares: -100
Change %: -0%
Price: $28.96
Shares after: 2,904,031
Date: 03 Sep 2025
Ownership: By Charming Jade Limited
Footnotes: F2, F3

CGON transaction

Common Stock

Sale

Transaction value: $2,899
Shares: -100
Change %: -0%
Price: $28.99
Shares after: 2,903,931
Date: 03 Sep 2025
Ownership: By Charming Jade Limited
Footnotes: F2, F3

CGON holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 586,982
Date: 03 Sep 2025
Ownership: By Unique Diamond Investments Limited
Footnotes: F3, F5

CGON holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 613,928
Date: 03 Sep 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

Footnote F3

Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F5

Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.